{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:28:06Z","timestamp":1777778886816,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ghir.2003.12.015","type":"journal-article","created":{"date-parts":[[2004,2,29]],"date-time":"2004-02-29T05:12:04Z","timestamp":1078031524000},"page":"235-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment"],"prefix":"10.1016","volume":"14","author":[{"given":"T.","family":"Zimmermann-Belsing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Juul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Juul Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2003.12.015_BIB1","first-page":"422","article-title":"Somatomedin production by rat liver in organ culture III studies on the release of insulin-like growth factor and its carrier protein measured by radioligand assays. Effects of growth hormone, insulin and cortisol","volume":"99","author":"Binoux","year":"1982","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/joe.0.1370271","article-title":"Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat","volume":"137","author":"Phillips","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2362.1993.tb00958.x","article-title":"The insulin-like growth factor-I\/binding protein axis: physiology, pathophysiology and therapeutic manipulation","volume":"23","author":"Langford","year":"1993","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ghir.2003.12.015_BIB4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000180553","article-title":"Somatomedin (insulin-like growth factors)-binding proteins. Molecular forms and regulation","volume":"24","author":"Binoux","year":"1986","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2003.12.015_BIB5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198707163170303","article-title":"Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults","volume":"317","author":"Guler","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2003.12.015_BIB6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/endo-128-4-1723","article-title":"The differential regulation by glucagon and growth hormone of insulin-like growth factor (IGF)-I and IGF binding proteins in cultured rat hepatocytes","volume":"128","author":"Kachra","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2003.12.015_BIB7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/endo-113-1-297","article-title":"Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status","volume":"113","author":"Schwander","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2003.12.015_BIB8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.ph.55.030193.001023","article-title":"The insulin-like growth factors","volume":"55","author":"Cohick","year":"1993","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1210\/jcem-51-1-12","article-title":"The somatomedin C binding protein: evidence for a heterologous subunit structure","volume":"51","author":"Furlanetto","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000184186","article-title":"Insulin-like growth factor binding proteins in the human circulation: a review","volume":"42","author":"Baxter","year":"1994","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2003.12.015_BIB11","first-page":"1883","article-title":"Immunoblot studies of the IGF-related acid-labile subunit","volume":"79","author":"Liu","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB12","first-page":"1871","article-title":"Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver","volume":"79","author":"Arany","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB13","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/endo.134.6.7515002","article-title":"Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex","volume":"134","author":"Chin","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2003.12.015_BIB14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/jcem-67-2-265","article-title":"Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex","volume":"67","author":"Baxter","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB15","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1016\/S0021-9258(18)80143-0","article-title":"High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum","volume":"264","author":"Baxter","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2003.12.015_BIB16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jcem-70-5-1347","article-title":"Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex","volume":"70","author":"Baxter","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1651-2227.1990.tb11634.x","article-title":"Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3","volume":"367","author":"Blum","year":"1990","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.ghir.2003.12.015_BIB18","first-page":"1610","article-title":"Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein-3 reflect spontaneous growth hormone secretion","volume":"76","author":"Blum","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB19","first-page":"1343","article-title":"Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism","volume":"81","author":"Ramos-Dias","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2265.1995.tb02923.x","article-title":"Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone","volume":"43","author":"Ramos-Dias","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2265.1999.00822.x","article-title":"Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients","volume":"51","author":"Ramos-Dias","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB22","first-page":"504","article-title":"Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism","volume":"127","author":"Giustina","year":"1992","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1530\/eje.0.1330646","article-title":"Influence of thyroid hormones on the regulation of growth hormone secretion","volume":"133","author":"Giustina","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2265.1993.tb00348.x","article-title":"Influence of hyperthyroidism on growth hormone secretion","volume":"38","author":"Valcavi","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-72-1-108","article-title":"Nature of altered growth hormone secretion in hyperthyroidism","volume":"72","author":"Iranmanesh","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0026-0495(97)90142-6","article-title":"Effects of experimentally induced mild hyperthyroidism on growth hormone and insulin secretion and sex steroid levels in healthy young men","volume":"46","author":"Lovejoy","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.12.015_BIB27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0026-0495(96)90275-9","article-title":"Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism","volume":"45","author":"Tosi","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2003.12.015_BIB28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/105072501753271734","article-title":"Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction","volume":"11","author":"Iglesias","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2003.12.015_BIB29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1677\/jme.0.0100313","article-title":"Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight\/body weight change during abnormal thyroid function?","volume":"10","author":"Thomas","year":"1993","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB30","first-page":"950","article-title":"Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone","volume":"76","author":"Miell","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-978868","article-title":"Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves\u2019 disease","volume":"30","author":"Wan Nazaimoon","year":"1998","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2003.12.015_BIB32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/thy.2000.10.417","article-title":"Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism","volume":"10","author":"Lakatos","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2003.12.015_BIB33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-2007-978798","article-title":"Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases","volume":"31","author":"Inukai","year":"1999","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2003.12.015_BIB34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/JPEM.2000.13.8.1073","article-title":"Effect of hyperthyroidism on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in adolescent children","volume":"13","author":"Co Ng","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/endo.132.2.7678799","article-title":"Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated","volume":"132","author":"Nanto-Salonen","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2003.12.015_BIB36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/eje.0.1380095","article-title":"Effects of thyroid status on insulin-like growth factor-I, growth hormone and insulin are modified by food intake","volume":"138","author":"Morovat","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB37","first-page":"E840","article-title":"Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats","volume":"269","author":"Frystyk","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2265.1993.tb00352.x","article-title":"Thyroxine treatment increases circulating levels of insulin-like growth factor binding protein-1: a placebo-controlled study","volume":"38","author":"Angervo","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB39","first-page":"4269","article-title":"Body weight and body composition changes after treatment of hyperthyroidism","volume":"83","author":"Lonn","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1380001","article-title":"The role of thyroid hormones in depression","volume":"138","author":"Kirkegaard","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB41","first-page":"185","article-title":"Intellectual impairment after hyperthyroidism","volume":"112","author":"Perrild","year":"1986","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2265.1998.00627.x","article-title":"The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects","volume":"49","author":"Zimmermann-Belsing","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2007-978666","article-title":"Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation","volume":"32","author":"Schott","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2003.12.015_BIB44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-8981(00)00385-5","article-title":"Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves\u2019 disease treated with antithyroid drugs","volume":"304","author":"Massart","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ghir.2003.12.015_BIB45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08916939109007650","article-title":"Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases","volume":"9","author":"Feldt-Rasmussen","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ghir.2003.12.015_BIB46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/clinchem\/42.6.942","article-title":"Radioimmunoassay of leptin in human plasma","volume":"42","author":"Ma","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2003.12.015_BIB47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/bbrc.1996.0579","article-title":"Development of radioimmunoassay for human leptin","volume":"221","author":"Hosoda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2003.12.015_BIB48","first-page":"99","article-title":"Lean body mass by dual energy X-ray absorptiometry (DEXA) and by urine and dialysate creatinine recovery in CAPD and pre-dialysis patients compared to normal subjects","volume":"10","author":"Nielsen","year":"1994","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.ghir.2003.12.015_BIB49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1475-097X.1991.tb00662.x","article-title":"Validation of body composition by dual energy X-ray absorptiometry (DEXA)","volume":"11","author":"Haarbo","year":"1991","journal-title":"Clin. Physiol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1152\/jappl.1997.82.4.1200","article-title":"Body composition analysis by DEXA by using dynamically changing samarium filtration","volume":"82","author":"Gotfredsen","year":"1997","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB51","first-page":"744","article-title":"Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index","volume":"78","author":"Juul","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB52","first-page":"2497","article-title":"Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency","volume":"82","author":"Juul","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB53","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jcem.83.12.5311","article-title":"The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency","volume":"83","author":"Juul","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB54","first-page":"2534","article-title":"Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation","volume":"80","author":"Juul","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.1994.tb03788.x","article-title":"The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients","volume":"41","author":"Juul","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X","article-title":"Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation","volume":"13","author":"Yu","year":"1999","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ghir.2003.12.015_BIB57","first-page":"161","article-title":"Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy","volume":"6","author":"Langdahl","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2003.12.015_BIB58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/eje.0.1310041","article-title":"Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset","volume":"131","author":"Juul","year":"1994","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.0.1490257","article-title":"Circulating leptin and thyroid dysfunction","volume":"149","author":"Zimmermann-Belsing","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1507\/endocrj.41.541","article-title":"Change in serum concentration of insulin-like growth factor II (IGF-II) in patients with thyroid disease","volume":"41","author":"Tada","year":"1994","journal-title":"Endocr. J."},{"key":"10.1016\/j.ghir.2003.12.015_BIB61","first-page":"925","article-title":"Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves\u2019 disease","volume":"93","author":"Hsiao","year":"1994","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ghir.2003.12.015_BIB62","first-page":"145","article-title":"Characterization of insulin-like growth factor receptors in human thyroid tissue","volume":"2","author":"Cissewski","year":"1992","journal-title":"Receptor"},{"key":"10.1016\/j.ghir.2003.12.015_BIB63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01738699","article-title":"Thyroid hormone action on intermediary metabolism. Part III. Protein metabolism in hyper- and hypothyroidism","volume":"62","author":"Muller","year":"1984","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.ghir.2003.12.015_BIB64","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism","volume":"69","author":"Jorgensen","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2003.12.015_BIB65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2265.1999.00667.x","article-title":"Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677","volume":"50","author":"Svensson","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.12.015_BIB67","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/35007527","article-title":"Towards a molecular understanding of adaptive thermogenesis","volume":"404","author":"Lowell","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.12.015_BIB68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2003.12.015_BIB69","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ghir.2003.12.015_BIB70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.1998.00571.x","article-title":"Leptin: in search of role(s) in human physiology and pathophysiology","volume":"49","author":"Mantzoros","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2281.1998.00129.x","article-title":"Leptin: physiology and pathophysiology","volume":"18","author":"Fruhbeck","year":"1998","journal-title":"Clin. Physiol."},{"key":"10.1016\/j.ghir.2003.12.015_BIB72","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI9725","article-title":"Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring","volume":"105","author":"Flier","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2003.12.015_BIB73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.1996.636458.x","article-title":"Beta-cell function and glucose and lipid oxidation in Graves\u2019 disease","volume":"44","author":"Bech","year":"1996","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2003.12.015_BIB74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2265.2000.00907.x","article-title":"Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin","volume":"52","author":"Fernandez-Real","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:40:32Z","timestamp":1761086432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637404000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1096637404000085"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2003.12.015","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2003.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}